Keating & Associates

Lobbying Organisation Keating & Associates

Date published 30 Apr, 2020

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan, 2020 to 30 Apr, 2020

Specific Details Medical Cannabis Access Programme (MCAP)

Intended results Facilitate an introduction to our client Spectrum Biomedical; gain insights into potential future direction of the Medical Cannabis Access ProgrammeMCAP

Name of person primarily responsible for lobbying on this activity Leah Mullally

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? Yes

Client(s)

Client 1

Company name Spectrum Biomedical

CRO number (if applicable)

Company address 1 Hershey Drive, Smiths Falls, Ontario, Canada K7A 0A8

Main business or activity Health

Company website https://www.spectrumtherapeutics.com/international/en

Contact email address xavier.woodward@canopygrowth.com

Contact phone number 0044 (0) 77486 234 23

Contact address

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Alan Kelly TD (Dáil Éireann, the Oireachtas)

Kate O'Connell TD (Dáil Éireann, the Oireachtas)

Michael Harty TD (Dáil Éireann, the Oireachtas)